Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Connolly

Showing results (341-350 of 380) with videos related to

Pageof 38
Sort By:
Diabetes Research and Clinical Practice|February 6, 2022
Population-centric risk prediction modeling for gestational diabetes mellitus: A machine learning approachMukkesh Kumar, Li Chen, Karen Tan, et al.
Diabetes|June 22, 2022
Carbonyl Posttranslational Modification Associated With Early-Onset Type 1 Diabetes AutoimmunityMei-Ling Yang, Sean E Connolly, Renelle J Gee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 4, 2013
Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and/or locally recurrent nasopharyngeal carcinomaWhay-Kuang Chia, Marissa Teo, Who-Whong Wang, et al.
Molecular Cancer Therapeutics|June 23, 2021
Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T CellsWen-Hsin Sandy Lee, Zhiyong Ye, Alice M S Cheung, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengueKuan Rong Chan, Eugenia Z Ong, Hwee Cheng Tan, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 9, 2018
Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trialK Kalinsky, J A Sparano, X Zhong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 10, 2020
Monocytic Myeloid-Derived Suppressor Cells Underpin Resistance to Adoptive T Cell Therapy in Nasopharyngeal CarcinomaRichard Hopkins, Wenwei Xiang, Damien Marlier, et al.
Journal for Immunotherapy of Cancer|May 12, 2025
Associations between immune checkpoint inhibitor response, immune-related adverse events, and steroid use in RADIOHEAD: a prospective pan-tumor cohort studyZoe Quandt, Anastasia Lucas, Samantha I Liang, et al.
Blood Advances|October 6, 2025
FLT3-ITD measurable residual disease from the QuANTUM-First trialMark J Levis, Harry P Erba, Pau Montesinos, et al.
Science Translational Medicine|June 5, 2015
Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patientsHelen Benham, Hendrik J Nel, Soi Cheng Law, et al.
Pageof 38

Showing results (341-350 of 380) with videos related to

Sort By:
Pageof 38
Diabetes Research and Clinical Practice|February 6, 2022
Population-centric risk prediction modeling for gestational diabetes mellitus: A machine learning approachMukkesh Kumar, Li Chen, Karen Tan, et al.
Diabetes|June 22, 2022
Carbonyl Posttranslational Modification Associated With Early-Onset Type 1 Diabetes AutoimmunityMei-Ling Yang, Sean E Connolly, Renelle J Gee, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 4, 2013
Adoptive T-cell transfer and chemotherapy in the first-line treatment of metastatic and/or locally recurrent nasopharyngeal carcinomaWhay-Kuang Chia, Marissa Teo, Who-Whong Wang, et al.
Molecular Cancer Therapeutics|June 23, 2021
Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T CellsWen-Hsin Sandy Lee, Zhiyong Ye, Alice M S Cheung, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 20, 2014
Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengueKuan Rong Chan, Eugenia Z Ong, Hwee Cheng Tan, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 9, 2018
Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trialK Kalinsky, J A Sparano, X Zhong, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 10, 2020
Monocytic Myeloid-Derived Suppressor Cells Underpin Resistance to Adoptive T Cell Therapy in Nasopharyngeal CarcinomaRichard Hopkins, Wenwei Xiang, Damien Marlier, et al.
Journal for Immunotherapy of Cancer|May 12, 2025
Associations between immune checkpoint inhibitor response, immune-related adverse events, and steroid use in RADIOHEAD: a prospective pan-tumor cohort studyZoe Quandt, Anastasia Lucas, Samantha I Liang, et al.
Blood Advances|October 6, 2025
FLT3-ITD measurable residual disease from the QuANTUM-First trialMark J Levis, Harry P Erba, Pau Montesinos, et al.
Science Translational Medicine|June 5, 2015
Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patientsHelen Benham, Hendrik J Nel, Soi Cheng Law, et al.
Pageof 38